Pub. Date : 2015 Jun
PMID : 25809543
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | PURPOSE: Preclinical data indicate there is strong synergism of action against Ewing sarcoma in sequential treatment with trabectedin followed by irinotecan and it appears to be related to a selective blockade of the transcription factor EWS-FLI1. | Trabectedin | Fli-1 proto-oncogene, ETS transcription factor | Homo sapiens |